Setting a new standard in patient compliance and diagnostic yield

Precise, reliable, cardiac rhythm analysis.

Zio by iRhythm captures beat-to-beat cardiac rhythm for up to 14 days, continuously recording and storing both symptomatic and asymptomatic events 24 hours a day. Diagnostic yield is 57% greater with the Zio system than traditional Holter monitoring.1

1Barrett, P., et al. Comparison of 24 Hour Holter Monitoring Versus 14 Day Novel Adhesive Patch Electrocardiographic Monitoring. American Journal of Medicine, 2014.

GET A MORE RELIABLE DIAGNOSIS, QUICKLY

  • Complete data with the first test—With Zio's 14-day monitoring period, compared to just one or two days with traditional ambulatory cardiac monitoring.
  • Better, more informed treatment decisions are enabled by the comprehensive, actionable Zio report.
FIND OUT MORE
Patients
Wearing ZIO

An easy patient experience + proprietary diagnostic algorithm yields trustworthy reporting.

  • Zio monitor – The water-resistant, wire-free, single-use Zio patch is discreet and easy to wear, even while sleeping or during moderate exercise, making it easy to capture up to 14 days of continuous heartbeats. Comprehensive data collection helps ensure detection of infrequent or asymptomatic arrhythmias.
  • Proprietary algorithm – Our proprietary algorithm identifies arrhythmias by analyzing the data that is collected by the patch.
  • Zio report – A comprehensive and easy-to-read summary derived from iRhythm's proprietary algorithms and quality assurance by certified cardiac technicians.

In a study, physicians were able to reach a diagnosis 90% of the time with the Zio system. More cost-efficient than other ambulatory cardiac monitoring methods.2

Indications for use: The Zio extended continuous ambulatory monitor is indicated for use in patients who may be asymptomatic or who may suffer from transient symptoms such as palpitations, shortness of breath, dizziness, lightheadedness, pre-syncope, syncope, fatigue, or anxiety.

2 Barret P., et al. Comparison of 24 Hour Holter Monitoring Versus 14 Day Novel Adhesive Patch Electrocardiographic Monitoring. American Journal of Medicine, 2014.